Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker GSK
Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker contracted to make UK’s coronavirus jabs Sir Patrick was president of multinationals drugs giant GSK from 2012 to 2018 Chief Scientific Adviser holds a deferred bonus of 43,111 shares worth £600,000 He has already cashed in … Read more